Sarah Elizabeth Slater, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Azasteroids | 1 | 2012 | 37 | 0.390 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2012 | 112 | 0.360 |
Why?
|
| Prostatic Hyperplasia | 1 | 2012 | 523 | 0.290 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 1536 | 0.220 |
Why?
|
| Hematology | 1 | 2024 | 243 | 0.180 |
Why?
|
| Neutropenia | 1 | 2023 | 892 | 0.150 |
Why?
|
| Palliative Care | 2 | 2023 | 3644 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 1134 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 3550 | 0.110 |
Why?
|
| Physicians | 2 | 2023 | 4615 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2024 | 2347 | 0.100 |
Why?
|
| Monosomy | 1 | 1992 | 52 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1992 | 310 | 0.090 |
Why?
|
| Finasteride | 1 | 2012 | 86 | 0.090 |
Why?
|
| Vietnam | 2 | 2023 | 416 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 11206 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 4049 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11844 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 420 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5443 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 1992 | 1322 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2023 | 631 | 0.040 |
Why?
|
| Haiti | 1 | 2022 | 553 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3708 | 0.040 |
Why?
|
| Patient Selection | 1 | 2012 | 4266 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 269 | 0.040 |
Why?
|
| Attitude of Health Personnel | 2 | 2023 | 3922 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 402 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 438 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1852 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3623 | 0.030 |
Why?
|
| Pain | 2 | 2023 | 5096 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1999 | 531 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2023 | 1737 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1395 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21157 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 1999 | 1081 | 0.030 |
Why?
|
| Mastectomy | 1 | 2022 | 1852 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 1992 | 5887 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 6527 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 2411 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 24310 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1999 | 1557 | 0.020 |
Why?
|
| Karyotyping | 1 | 1992 | 1173 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3939 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1677 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 9425 | 0.020 |
Why?
|
| Humans | 9 | 2024 | 768369 | 0.020 |
Why?
|
| Education, Medical | 1 | 2019 | 1742 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 65408 | 0.020 |
Why?
|
| Mitomycin | 1 | 2007 | 264 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 169424 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 74915 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 22365 | 0.010 |
Why?
|
| Camptothecin | 1 | 2007 | 594 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4538 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3837 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13589 | 0.010 |
Why?
|
| Female | 5 | 2023 | 396926 | 0.010 |
Why?
|
| Cisplatin | 1 | 2007 | 1661 | 0.010 |
Why?
|
| Male | 4 | 2019 | 364761 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4861 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6537 | 0.010 |
Why?
|
| United States | 1 | 2024 | 73120 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 82051 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 223406 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1999 | 1139 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81835 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60038 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 223528 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 6087 | 0.010 |
Why?
|
| Quality of Life | 1 | 2007 | 13497 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 20763 | 0.000 |
Why?
|